Abstract
Protein C (PC) deficiency is a rare disease with an incidence of 0.2 % in the general population. Because PC deficiency is likely to be thrombogenic, particularly in the venous system, continuous anticoagulant therapy is required, and when undergoing surgical treatment, such patients are considered a high-risk group. To our knowledge, the current case is the first report of successful pancreaticoduodenectomy for a patient with PC deficiency. A 46-year-old man with PC deficiency was referred to our hospital for cancer of the head of the pancreas. He had been managed with oral warfarin and baby-strength aspirin to prevent thrombotic disorders. A right adrenal pheochromocytoma was also diagnosed. Laparoscopic adrenalectomy was first performed. In spite of strict perioperative management with administration of heparin, deep venous thrombosis developed in the right femoral vein on postoperative day 8. On elective pancreaticoduodenectomy 19 days after the adrenalectomy, taking into account the postoperative course after the urological surgery, perioperative management of anticoagulant therapy was performed as follows: (1) preoperative intravenous administration of heparin up to 6 h before surgery; (2) on the day of the surgery, the heparin administration was discontinued, and dried concentrated human activated PC formulation (APC) was started intravenously from 6 h before the surgery at a dose of 210 U/kg/day. (3) Postoperatively, after the confirmation of hemostasis, the heparin administration was resumed on day 2. APC administration was discontinued as soon as the ongoing administration of APC was completed on day 2. During operation, no abnormal findings pertaining to hemostasis or thrombosis were observed. On his postoperative course, no new thrombus formation was identified. For patients with PC deficiency, there has been no clear standardized regimen for antithrombotic prophylaxis in surgical procedures. The prophylactic administration of APC might ensure a higher level of safety than that offered by surgery with the intraoperative administration of heparin or without the intraoperative administration of anticoagulants.
Similar content being viewed by others
References
Tait RC, Walker ID, Reitsma PH et al (1995) Prevalence of protein C deficiency in the healthy population. Thromb Haemost 73(1):87–93
Allaart CF, Poort SR, Rosendaal FR et al (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341(8838):134–138
Douketis JD, Spyropoulos AC, Spencer FA et al (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(Suppl 2):e326S–350S
Sakata T, Kario K, Katayama Y et al (2000) Studies on congenital protein C deficiency in Japanese: prevalence, genetic analysis, and relevance to the onset of arterial occlusive diseases. Semin Thromb Hemost 26(1):11–16
Toupance O, Nguyen P, Brandt B et al (1994) Prevention of vascular thrombosis by human purified protein C concentrate in a patient with familial PC deficiency undergoing renal transplantation. Transpl Int 7(2):144–145
Takikawa Y, Watanabe Y, Sawara K et al (2005) Successful perioperative management with activated protein C preparation for a surgical patient with gastric cancer who had multifocal deep venous thrombosis due to congenital protein C deficiency. J Iwate Med Assoc 57(1):63–70
Thakkar SC, Streiff MB, Bruley DF et al (2010) Case report: perioperative use of protein C concentrate for protein C deficiency in THA. Clin Orthop Relat Res 468(7):1986–1990
Manco-Johnson M, Nuss R (1992) Protein C concentrate prevents peripartum thrombosis. Am J Hematol 40(1):69–70
Richards EM, Makris M, Preston FE (1997) The successful use of protein C concentrate during pregnancy in a patient with type 1 protein C deficiency, previous thrombosis and recurrent fetal loss. Br J Haematol 98(3):660–661
Sharrock NE, Go G, Sculco TP et al (1999) Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement. Anesthesiology 90(4):981–987
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Futagawa, Y., Okui, N., Shimada, J. et al. Pancreaticoduodenectomy in a patient with protein C deficiency. Int Canc Conf J 4, 241–244 (2015). https://doi.org/10.1007/s13691-015-0210-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-015-0210-1